These results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two guidance the notion of targeting ACKR3 as a novel technique to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Conditions. We independently investigate, critique, and recommend https://robertm173asj1.anchor-blog.com/profile